Neglected Tropical Diseases

Medicine & Life Sciences

1. Ethiopia 100%
2. Visceral Leishmaniasis 88%
3. Guinea 49%
4. HIV 46%
5. Disease Outbreaks 36%
6. Ebola Hemorrhagic Fever 35%
7. Cambodia 33%
8. Cutaneous Leishmaniasis 27%
9. Sierra Leone 20%
10. Coinfection 18%
11. Belgium 17%
12. Zika Virus 16%
13. Leishmaniasis 16%
14. Therapeutics 15%
15. Hepacivirus 15%
16. Routine Diagnostic Tests 15%
17. Tuberculosis 15%
18. HIV Infections 14%
19. Malaria 13%
20. Myanmar 13%
21. Chikungunya virus 13%
22. Retrospective Studies 13%
23. Democratic Republic of the Congo 13%
24. Polymerase Chain Reaction 13%
25. Hepatitis C 12%
26. Cohort Studies 11%
27. miltefosine 11%
28. Leishmania 11%
29. Recurrence 11%
30. Eastern Africa 11%
31. Schistosomiasis 11%
32. Clinical Trials 11%
33. Microscopy 11%
34. Genotype 10%
35. Pentamidine 10%
36. Zika Virus Infection 10%
37. Cross-Sectional Studies 10%
38. Fever 9%
39. Elephantiasis 9%
40. Africa South of the Sahara 9%
41. liposomal amphotericin B 8%
42. Antibodies 8%
43. Mortality 8%
44. Paromomycin 8%
45. Antimony Sodium Gluconate 8%
46. Neglected Diseases 8%
47. Referral and Consultation 8%
48. Antigens 7%
49. Leprosy 7%
50. Child 7%
51. Health Facilities 7%
52. Aspirations (Psychology) 7%
53. Vaccines 7%
54. Treatment Failure 7%
55. Virus Diseases 7%
56. Survivors 6%
57. Aruba 6%
58. Infection 6%
59. Skin 6%
60. Enzyme-Linked Immunosorbent Assay 6%
61. Confidence Intervals 6%
62. CD4 Lymphocyte Count 6%
63. Monkeypox virus 6%
64. Epidemics 6%
65. Sensitivity and Specificity 6%
66. Safety 6%
67. picaridin 6%
68. Monkeypox 6%
69. Schistosoma 6%
70. Pandemics 5%
71. Delivery of Health Care 5%
72. Tropical Medicine 5%
73. Evaluation Studies 5%
74. 2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole 5%
75. MK-5172 5%
76. Guidelines 5%
77. Mass Drug Administration 5%
78. Insect Repellents 5%
79. Sudan 5%
80. Emergencies 5%
81. Swaziland 5%
82. Scabies 5%
83. Serum 5%